Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.94 USD | +0.43% | -5.96% | -20.69% |
Jun. 05 | Morgan Stanley Adjusts COMPASS Pathways Price Target to $23 From $30, Maintains Overweight Rating | MT |
Jun. 04 | FDA panel to review psychedelic drug MDMA for first time | RE |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
COMPASS PATHWAYS PLC | Other Biotechnology & Medical Research | +0.43% | -5.96% | -20.69% | -15.98% | - | 473M |
Technical Rankings Surperformance
- Stock Market
- Equities
- CMPS Stock
- Charts COMPASS Pathways plc
- Comparison Chart